TCM
IGC icon

Triumph Capital Management’s IGC Pharma IGC Stock Holding History

Triumph Capital Management’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
2
– – ﹤0.01% 1861
2026
Q1 		$1 Hold
2
– – ﹤0.01% 1836
2025
Q4 		$1 Buy
+2
New +$1 ﹤0.01% 1769

Other funds holding IGC

LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Triumph Capital Management's IGC Position: Q2 2026 in Review

Triumph Capital Management held its IGC Pharma (IGC) position steady in Q2 2026 at 2 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1861.

Triumph Capital Management first reported a position in IGC in Q4 2025 and has held it in 3 quarters since. 4 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Triumph Capital Management held 2 shares of IGC Pharma worth $1 as of Q2 2026.
  • Triumph Capital Management left its IGC Pharma share count unchanged in Q2 2026.
  • IGC Pharma made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1861 holding.
  • Triumph Capital Management first reported a position in IGC Pharma in Q4 2025 and has held it in 3 quarters since.
  • 4 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.